gallic acid has been researched along with Triple Negative Breast Neoplasms in 3 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Graminha, AE | 2 |
| Honorato, J | 2 |
| Correa, RS | 1 |
| Cominetti, MR | 2 |
| Menezes, ACS | 2 |
| Batista, AA | 2 |
| Lee, HL | 1 |
| Lin, CS | 1 |
| Kao, SH | 1 |
| Chou, MC | 1 |
| Naves, MA | 1 |
| Vegas, LC | 1 |
| Luna-Dulcey, L | 1 |
3 other studies available for gallic acid and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
A novel ruthenium(ii) gallic acid complex disrupts the actin cytoskeleton and inhibits migration, invasion and adhesion of triple negative breast tumor cells.
Topics: Actin Cytoskeleton; Animals; Antineoplastic Agents; Apoproteins; Biphenyl Compounds; Cell Adhesion; | 2021 |
Gallic acid induces G1 phase arrest and apoptosis of triple-negative breast cancer cell MDA-MB-231 via p38 mitogen-activated protein kinase/p21/p27 axis.
Topics: Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibito | 2017 |
Transport of the Ruthenium Complex [Ru(GA)(dppe)
Topics: Antineoplastic Agents; Apoptosis; Biological Transport, Active; Cell Line, Tumor; Cell Movement; Cis | 2019 |